Cancer-Related Morbidity Among Patients Conceiving Through Oocyte Donation: A Healthcare Registry Cohort Study
Journal of Women's Health · 2024
DOI: 10.1089/jwh.2024.0248 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Women's Health, 2024. Verfasst von Anat Hershko Klement und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Oocyte Donation, Neoplasms, Fertilization in Vitro, Registries. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Background
Ovarian aging, often leads to increased use of a donor oocyte, which is associated with greater risk for age-related diseases.
Objective
To evaluate the association between women conceiving through oocyte donation (OD) and future cancer-related morbidity, as compared with women conceiving through IVF (in vitro fertilization) with autologous oocytes (AO), spontaneous conceptions (SC), and nulliparas.
Methods
This retrospective, cohort study was based on the electronic health records of a very large health maintenance organization. The cohort included mothers who delivered before age 45, during 2000-2019. The index date for surveillance was the delivery date of the relevant pregnancy. Each woman from the OD group was matched to a woman the same age at delivery and with the same number of children. Cancer diagnosis was the main outcome.
Results
Matching: 664 OD cases to 664 AO, 700 OD cases to 700 SC, and 700 OD cases to 700 nulliparas. Mean follow-up times were 8.9 ± 3.8 OD, 10 ± 4.1 AO, and 6.4 ± 4.1 years SC. Cancer-related morbidity rates were comparable between OD and the other groups, but compared with nulliparas, a trend was noted (1.6% and 3.1%, respectively, p = 0.07). Survival analysis curves were not significantly different, although a trend was shown in the curve comparing to nulliparity (p = 0.07). In a Cox regression model corrected for BMI, smoking and hormone replacement therapy exposure, cancer in the OD group did not differ compared to the other groups.
Conclusion
Women conceiving through OD do not have increased risk for cancer-related morbidity in the decade following delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- IVF Unit, Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel.
- School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Department of Statistics and Data Science, Hebrew University of Jerusalem, Jerusalem, Israel.
- Mayanei Hayeshua Medical Center, IVF unit, Bnei Brak, Israel.
ORCID-Profile: Einat Haikin-Herzberger
Zitieren
APA
Hershko Klement, A., Asali, A., Shalev Ram, H., Haikin-Herzberger, E., Shlezinger, R., Wiser, A., & Miller, N. (2024). Cancer-Related Morbidity Among Patients Conceiving Through Oocyte Donation: A Healthcare Registry Cohort Study. Journal of Women's Health. https://doi.org/10.1089/jwh.2024.0248
Vancouver
Hershko Klement A, Asali A, Shalev Ram H, Haikin-Herzberger E, Shlezinger R, Wiser A, et al. Cancer-Related Morbidity Among Patients Conceiving Through Oocyte Donation: A Healthcare Registry Cohort Study. Journal of Women's Health. 2024. doi:10.1089/jwh.2024.0248
BibTeX
@article{HershkoKlement2024,
author = {Hershko Klement, Anat and Asali, Aula and Shalev Ram, Hila and Haikin-Herzberger, Einat and Shlezinger, Roi and Wiser, Amir and Miller, Netanella},
title = {Cancer-Related Morbidity Among Patients Conceiving Through Oocyte Donation: A Healthcare Registry Cohort Study},
journal = {Journal of Women's Health},
year = {2024},
doi = {10.1089/jwh.2024.0248}
}
EUVIMED